Expeditors International of Wshngtn Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Expeditors International of Wshngtn Inc trades at $197.41 (market cap $25.53B), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: Expeditors International of Wshngtn Inc is far larger — about 3× Hinge Health Inc. Class A Common Stock's market cap, and Expeditors International of Wshngtn Inc pays a 0.82% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expeditors International of Wshngtn Inc for 44 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| EXPD | HNGE | |
|---|---|---|
Market Cap | $25.53B | $8.47B |
Volume | 1,068,336 | 1,624,526 |
Sector | Industrials | Health |
52-Week High | $196.38 | $105.14 |
52-Week Low | $117.35 | $31.17 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $25.06B | $8.09B |
Dividend Yield | 0.82% | — |
Signals from Pluang's Aura AI — not financial advice
EXPD trades at $195.13, up 0.89% today, with strong technical momentum showing bullish moving averages and trading near resistance at $196. The company demonstrates robust fundamentals with three consecutive quarterly earnings beats, ROE of 42.6%, and revenue growth from $10.6B to $11.1B in 2025. Recent news highlights efficiency initiatives and AI-driven freight market opportunities.
Outlook remains positive with earnings momentum and operational efficiency gains, though valuation appears stretched at 28.4 P/E. Key risks include freight market volatility and competitive pressures. Analyst consensus is cautious with 63.6% hold ratings and $179.43 target below current price, suggesting limited near-term upside despite strong fundamentals.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →